Search the database for deliberate release of GM medicinal products
Displaying 1 - 2 of 2
|EU record number
|Company / Sponsor
|Only notified under the "contained use" procedure. Dossier submitted on 23/04/2012.
|Randomized Phase III of haploidentical HCT with or without an add back strategy of HSV-Tk donor lymphocytes in patients with high risk acute leukemia
|-Thymidine Kinase (HSV-Tk) - selection marker
|Only notified under the "contained use" procedure. Dossier submitted on 11/07/2002.
|A European and Canadian multicenter, randomized, double-blind, placebo controlled study to evaluate the efficacy and safety of Ad5FGF-4 in patients with stable angina